| Patents for A61P 13 - Drugs for disorders of the urinary system (56,135) |
|---|
| 08/11/2004 | EP1443917A1 Tamsulosin tablets |
| 08/11/2004 | EP1443913A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 08/11/2004 | EP1363677A4 Method of using a variant of vegf receptor to treat psoriasis and to enhance wound healing |
| 08/11/2004 | EP1358182B1 Diazocine derivatives and their use as tryptase inhibitors |
| 08/11/2004 | EP1155003B1 Novel guanidine derivatives as inhibitors of cell adhesion |
| 08/11/2004 | EP1154988B1 Mevinolin derivatives |
| 08/11/2004 | EP1147095B1 2, 3, 4, 5-tetrahydro-1h-[1, 4] benzodiazepine-3-hydroxamic acids as matrix metalloproteinase inhibitors |
| 08/11/2004 | CN1520409A Piperazine oxime derivatives having Nk-1 receptor antagonistic activity |
| 08/11/2004 | CN1520404A Piperazinylpyrazines compounds as antagonists of serotonin-5-HT2 receptor |
| 08/11/2004 | CN1520403A Novel polymorph v of torasemide |
| 08/11/2004 | CN1520324A Antiangiogenic combination thereapy for treatment of cancer |
| 08/11/2004 | CN1520314A Drugs contg. chymase inhibitor and ace inhibitors as active ingredients |
| 08/11/2004 | CN1520303A Turnor therapy with alphavirus-based and high affinity laminin receptor-targeted vectors |
| 08/11/2004 | CN1520300A Dihydro-triterpenes in treatment of viral infections, cardiovascular disease, inflammation, hypersensitivity or pain |
| 08/11/2004 | CN1520299A Use of compounds with combined NEP/MP-inbihitory activity in prepan. of medicaments |
| 08/11/2004 | CN1520298A Pyrazolopyrimidines as therapeutic agents |
| 08/11/2004 | CN1520291A Fumaric acid derivatives as NF-Kappab inhibitors |
| 08/11/2004 | CN1519004A Prepared Chinese medicine for treating dribble urination caused by accumlated damp-heat and urination distrubance disease with dripping wet and unsmooth |
| 08/11/2004 | CN1518977A Combination of levogyrate bicalutamide |
| 08/11/2004 | CN1161356C Puring inhibitors of cylin dependent kinase 2 and I'kappa'beta-'alpha' |
| 08/11/2004 | CN1161352C Quinazoline derivatives |
| 08/11/2004 | CN1161338C Fluorinated 3,4-dihydroquinoline derivatives used and NOS inhibitors |
| 08/11/2004 | CN1161140C Medicine for preventing and treating coronary heart disease and angina pectoris and its prepn and other use |
| 08/11/2004 | CN1161134C Medicine for treating renal calculus and its preparing process |
| 08/11/2004 | CN1161133C Liposoluble Chinese medicine rectal suppository for treating acute and chronic prostatitis |
| 08/10/2004 | US6774217 Use of fragile histidine triad gene (fhit) genes and their encoded proteins as diagnostic and therapeutic reagents for the detection and treatment of disease states associated with cell overproliferation |
| 08/10/2004 | US6774136 Substituted 1 and 2 naphthol mannich bases |
| 08/10/2004 | US6774127 Pyrazole and pyrazoline substituted compounds |
| 08/10/2004 | US6774118 Therapeutic use of CIS-element decoys in vivo |
| 08/10/2004 | US6774112 Antidiabetic agents; cardiovascular disorders |
| 08/10/2004 | US6773714 Polymeric delivery formulations of leuprolide with improved efficacy |
| 08/10/2004 | CA2311354C Transdermal therapeutic system (tts) containing oxybutynin |
| 08/05/2004 | WO2004065960A1 Novel screening method |
| 08/05/2004 | WO2004065392A1 Condensed pyridines and pyrimidines and their use as alk-5 receptor ligands |
| 08/05/2004 | WO2004065365A1 8-azaprostaglandin derivatives and medicinal uses thereof |
| 08/05/2004 | WO2004064821A1 Reduced dose of tolterodine and other antimuscarinic agents for treating urinary disorders |
| 08/05/2004 | WO2004064736A2 Treatment of benign prostatic hyperplasia using energolytic agents |
| 08/05/2004 | WO2004064735A2 Treatment of benign prostatic hyperplasia |
| 08/05/2004 | WO2004064716A2 Eicosapentaenoic acid and docosapentaenoic acid for treating inflammatory disorders |
| 08/05/2004 | WO2004056768A3 Use of substituted 2,5-diamidoindoles for the treatment of urological diseases |
| 08/05/2004 | WO2004041806A3 Substituted 4-amino-1-(pyridylmethyl) piperidine as muscarinic receptor antagonists |
| 08/05/2004 | WO2004022716A9 Recombinatant mutants of rhabdovirus and methods of use thereof |
| 08/05/2004 | WO2003042359A3 Histamine receptor h3 polynucleotides |
| 08/05/2004 | WO2002101357A3 Molecular signatures of commonly fatal carcinomas |
| 08/05/2004 | US20040152906 Sulfonamides |
| 08/05/2004 | US20040152893 Sulfonamides |
| 08/05/2004 | US20040152891 Sulfonamides |
| 08/05/2004 | US20040152785 Antiarthritic agents; bone disorders; oral diseases; nephritis; atherosclerosis; respiratory system disorders; cirrhosis; vision defects; anticancer agents; autoimmune diseases |
| 08/05/2004 | US20040152761 Dimeric isoflavones |
| 08/05/2004 | US20040152754 Cyclic AMP-specific phosphodiesterase inhibitors |
| 08/05/2004 | US20040152753 Methods of use for novel sulfur containing organic nitrate compounds |
| 08/05/2004 | US20040152738 Wound healing agents; antiarthritic agents; osteoporosis; congestive heart failure; antiulcer agents; Alzheimer's disease; anticholesterol agents; antiarthritic agents |
| 08/05/2004 | US20040152734 Substituted C-furan-2-yl-methylamine and C-thiophen-2-yl-methylamine compounds |
| 08/05/2004 | US20040152731 4-(Phenyl-(piperidin-4-yl)-amino)-benzamide derivaties and their use for the treatment of pain, anxiety or gastrointestinal disorders |
| 08/05/2004 | US20040152730 Novel compounds |
| 08/05/2004 | US20040152726 Quinoline-4-carboxamide derivatives as nk-3 and nk-2 receptor antagonists |
| 08/05/2004 | US20040152705 Pyrazino 1',2':1,6 pyrido 3,4-b indole1,4-dione derivatives |
| 08/05/2004 | US20040152692 Pyrrolidine sulfonamides |
| 08/05/2004 | US20040152662 Method for preventing, reducing, and treating radiation cystitis using hyaluronic acid |
| 08/05/2004 | US20040152157 G-protein coupled receptors |
| 08/05/2004 | US20040152143 Growth differentiation factor-9 |
| 08/05/2004 | US20040152139 for diagnosing/treating prostate cancer by administering immunoconjugates; gene expression inhibition; genetic engineering |
| 08/05/2004 | US20040151781 Osteoporosis, hormone-related disorders |
| 08/05/2004 | US20040151763 pH adjuster namely citric acid, preservative, and an anti-irritant agent, especially a local anesthetic, analgesic, anesthetic, antipruitic, astringent, hydrocortisone preparation, or keratolytic; feminine wipe |
| 08/05/2004 | DE10304374A1 Neue substituierte 2-Aminoimidazole, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament New substituted 2-Aminoimidazole, processes for their preparation, their use as a medicament or diagnostic, and they drug-containing |
| 08/05/2004 | CA2513575A1 Treatment of benign prostatic hyperplasia using energolytic agents |
| 08/05/2004 | CA2513572A1 Treatment of benign prostatic hyperplasia |
| 08/04/2004 | EP1443106A1 Somatic cell derived embryonic stem cells and its differentiated cells |
| 08/04/2004 | EP1443041A1 5-amidino-2-hydroxybenzenesulfonamide derivatives, medicinal compositions containing the same, medicinal use thereof and intermediates in the production thereof |
| 08/04/2004 | EP1442058A2 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 08/04/2004 | EP1442050A2 Linear basic compounds having nk-2 antagonist activity and formulations thereof |
| 08/04/2004 | EP1442049A2 Substituted amino ketone compounds |
| 08/04/2004 | EP1442042A1 Polycyclic guanine derivative phosphodiesterase v inhibitors |
| 08/04/2004 | EP1442040A1 Bridged bicycle (1,4) benzodiazepine vasopressin receptor antagonists |
| 08/04/2004 | EP1442039A1 Pyrimido (4,5-b) indole derivatives |
| 08/04/2004 | EP1442023A1 Crystalline sodium salt of telmisartan and the use of the same as an angiotensin antagonist |
| 08/04/2004 | EP1442021A1 Substituted 1h-quinolin-2-one compounds |
| 08/04/2004 | EP1441773A1 Pacap compositions and methods for tumor imaging and therapy |
| 08/04/2004 | EP1441754A1 Use of egf to inhibit pathogenic infections of the urogenital tract |
| 08/04/2004 | EP1441732A2 Thiazole derivative and pharmaceutical use thereof |
| 08/04/2004 | EP1441713A1 Modified release tamsulosin tablets |
| 08/04/2004 | EP1441707A1 Anti-muscarinic agent and estrogen-agonist for treating unstable or overactive bladder |
| 08/04/2004 | EP1441706A2 Antimuscarinic aerosol |
| 08/04/2004 | EP1441697A2 Conductance of improperly folded proteins through the secretory pathway and related methods for treating disease |
| 08/04/2004 | EP1441684A2 Methods and compositions for treating urological disorders using 313, 333, 5464, 18817 or 33524 |
| 08/04/2004 | EP1169054B1 Prognosis of ptp lar related diseases |
| 08/04/2004 | EP1140021B1 Improved formulation for topical non-invasive application in vivo |
| 08/04/2004 | EP1127071B1 Compounds with growth hormone releasing properties |
| 08/04/2004 | EP1126879A4 Gene therapy for regulating smooth muscle cell tone |
| 08/04/2004 | EP1064256B1 Bicyclo [2.2.1] heptanes and related compounds |
| 08/04/2004 | CN1518551A Triazaspiro [5,5] undecane derivatrives and drugs containing the same as active ingredient |
| 08/04/2004 | CN1518549A Novel piperidinecarboxamide derivatives, method for preparing same and pharmaceutical compositions containing same |
| 08/04/2004 | CN1518546A Selective anthranilamide pyridine amides as inhibitors of VEGRF-2 and VEGFR-3 |
| 08/04/2004 | CN1518542A Nicotinamide biaryl derivatives useful as inhibitors of PDE4 isozymes |
| 08/04/2004 | CN1518444A Use of substituted 6-dimethylaminomethyl-1-phenyl-cyclohexane compounds for treating urinary incontinence |
| 08/04/2004 | CN1160359C Dithiepino [6,5-b] pyridines, and related compsns. and methods for preparing and use |
| 08/04/2004 | CN1160356C Naphthyridine derivatives, processes for their preparation, their use and pharmaceutical compositions comprising them |
| 08/04/2004 | CN1160110C Chinese medicine boosting brain and supplementing kidney and its preparation method |
| 08/04/2004 | CN1160076C Pharmaceutical composition comprising bisphosphonic acid |
| 08/03/2004 | US6770743 Genetic engineered drug |